Advancing Targeted Drug Delivery: The Role of Smart Polymers in Responsive Therapeutic Systems.
ALSHAMRANI, A., AL HADI, A., AlMutairi, A., ALkhweildy, W., Aldubiban, G., Moafa, A., Alshehri, F., Alnami, M., Alqarni, A., Ayoub, Z., Banajia, M., Almutairi, H., Alnami, F., Safhi, A., Aldossary, F. (2024). Advancing Targeted Drug Delivery: The Role of Smart Polymers in Responsive Therapeutic Systems.. EKB Journal Management System, 67(13), 1549-1556. doi: 10.21608/ejchem.2024.337880.10836
ABDULLAH IBRAHEM ALSHAMRANI; ABDULMONEM YAHYA AL HADI; Abdullah Hamad AlMutairi; Wafa Saleh ALkhweildy; Ghada Mansour Aldubiban; Albader Mohammed Moafa; Fatimah Ali Mohammad Alshehri; Mohammed hussein Alnami; Ahmed Abdullah Alqarni; Zaki Hamad Ayoub; Mohammed Ali Banajia; hameed nasser hameed Almutairi; FatimMohammed bin Ahmed Alnami; Ahmed Mousa Ali Safhi; Fahad Khalid Mohammed Aldossary. "Advancing Targeted Drug Delivery: The Role of Smart Polymers in Responsive Therapeutic Systems.". EKB Journal Management System, 67, 13, 2024, 1549-1556. doi: 10.21608/ejchem.2024.337880.10836
ALSHAMRANI, A., AL HADI, A., AlMutairi, A., ALkhweildy, W., Aldubiban, G., Moafa, A., Alshehri, F., Alnami, M., Alqarni, A., Ayoub, Z., Banajia, M., Almutairi, H., Alnami, F., Safhi, A., Aldossary, F. (2024). 'Advancing Targeted Drug Delivery: The Role of Smart Polymers in Responsive Therapeutic Systems.', EKB Journal Management System, 67(13), pp. 1549-1556. doi: 10.21608/ejchem.2024.337880.10836
ALSHAMRANI, A., AL HADI, A., AlMutairi, A., ALkhweildy, W., Aldubiban, G., Moafa, A., Alshehri, F., Alnami, M., Alqarni, A., Ayoub, Z., Banajia, M., Almutairi, H., Alnami, F., Safhi, A., Aldossary, F. Advancing Targeted Drug Delivery: The Role of Smart Polymers in Responsive Therapeutic Systems.. EKB Journal Management System, 2024; 67(13): 1549-1556. doi: 10.21608/ejchem.2024.337880.10836

Advancing Targeted Drug Delivery: The Role of Smart Polymers in Responsive Therapeutic Systems.

Egyptian Journal of Chemistry
Volume 67, Issue 13, December 2024, Page 1549-1556  XML PDF (642.43 K)
Document Type: Review Articles
DOI: 10.21608/ejchem.2024.337880.10836
View on SCiNiTO View on SCiNiTO
Authors
ABDULLAH IBRAHEM ALSHAMRANI email 1; ABDULMONEM YAHYA AL HADI2; Abdullah Hamad AlMutairi3; Wafa Saleh ALkhweildy4; Ghada Mansour Aldubiban5; Albader Mohammed Moafa6; Fatimah Ali Mohammad Alshehri7; Mohammed hussein Alnami8; Ahmed Abdullah Alqarni9; Zaki Hamad Ayoub10; Mohammed Ali Banajia11; hameed nasser hameed Almutairi12; FatimMohammed bin Ahmed Alnami13; Ahmed Mousa Ali Safhi14; Fahad Khalid Mohammed Aldossary15
1Ksa, Ministry of health, Jeddah First health cluster , Executive Managment Operation
2Ksa, Ministry of health
3Ksa, Ministry of health, Branch of the Ministry of health in Riyadh Region
4Ksa, Ministry of health, Mansora primary health center
5Ksa, Ministry of health, Faisaliah primary health center
6Ksa, Ministry of health, Prince Mohammed Bin Nasser Hospital
7Ksa, Ministry of health, Pharmacist in the public Health Department Riyadh
8Ksa, Ministry of health, Riyadh
9Ksa, Ministry of health, Al Amajiya Health Center
10Ksa, Ministry of health, Jazan Health Complex
11Ksa, Ministry of health, Sabya General Hospital Jazan
12Ksa, Ministry of health, king saud hospital
13Ksa, Ministry of health, Branch of the Ministry of Health in Asir Region
14Ksa, Ministry of health, King Abdulaziz Hospital Jeddah
15Ksa, Ministry of health, Hotat Bani Tamim Hospital
Abstract
Background:

Targeted drug delivery systems have transformed modern therapeutics by enabling precise delivery of drugs to specific sites, thereby reducing systemic toxicity. Smart polymers, with their unique ability to respond to environmental and biological stimuli, have emerged as innovative materials for developing responsive therapeutic systems. These polymers enable controlled drug release in response to triggers such as pH, temperature, enzymatic activity, and light, providing a significant advantage over conventional delivery systems. Despite their potential, challenges such as scalability, biocompatibility, and regulatory hurdles remain barriers to widespread clinical adoption.

Aim:

This paper aims to explore the role of smart polymers in advancing targeted drug delivery systems, with a focus on their responsive mechanisms, therapeutic applications, and future potential.

Methods:

The paper synthesizes findings from peer-reviewed studies and experimental data to evaluate the design, function, and clinical applications of smart polymers. Key responsive mechanisms and their implementation in polymer-based systems such as hydrogels, micelles, and nanocarriers are analyzed. Comparative evaluations with non-responsive delivery systems and case studies of clinical applications are included.

Results:

Smart polymers demonstrate significant improvements in targeted delivery, including enhanced drug bioavailability, reduced systemic toxicity, and improved therapeutic outcomes. Successful applications are highlighted in oncology, diabetes management, and neurodegenerative disease treatments. Case studies reveal promising clinical trial outcomes, but challenges in cost, production, and regulatory compliance remain.

Conclusion:

Smart polymers represent a transformative advancement in drug delivery, providing responsive, patient-specific therapeutic solutions. Addressing current challenges through interdisciplinary innovation and integration with emerging technologies such as nanotechnology and artificial intelligence could unlock their full potential, improving the efficacy and accessibility of future therapies.
Keywords
Smart polymers; targeted drug delivery; responsive therapeutic systems; controlled drug release; biocompatibility; nanocarriers; clinical applications
Statistics
Article View: 418
PDF Download: 279